Show simple item record

Cost-effectiveness of Lifestyle Africa: an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa

dc.contributor.authorWhittington, Melanie D.
dc.contributor.authorGoggin, Kathy
dc.contributor.authorTsolekile, Lungiswa
dc.contributor.authorPuoane, Thandi
dc.contributor.authorFox, Andrew T.
dc.contributor.authorResnicow, Ken
dc.contributor.authorFleming, Kandace K.
dc.contributor.authorSmyth, Joshua M.
dc.contributor.authorMateria, Frank T.
dc.contributor.authorHurley, Emily A.
dc.contributor.authorVitolins, Mara Z.
dc.contributor.authorLambert, Estelle V.
dc.contributor.authorLevitt, Naomi S.
dc.contributor.authorCatley, Delwyn
dc.date.accessioned2023-06-12T20:58:27Z
dc.date.available2023-06-12T20:58:27Z
dc.date.issued2023-05-23
dc.identifier.citationWhittington, M. D., Goggin, K., Tsolekile, L., Puoane, T., Fox, A. T., Resnicow, K., Fleming, K. K., Smyth, J. M., Materia, F. T., Hurley, E. A., Vitolins, M. Z., Lambert, E. V., Levitt, N. S., & Catley, D. (2023). Cost-effectiveness of Lifestyle Africa: an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa. Global health action, 16(1), 2212952. https://doi.org/10.1080/16549716.2023.2212952en_US
dc.identifier.urihttps://hdl.handle.net/1808/34334
dc.description.abstractBackground Lifestyle Africa is an adapted version of the Diabetes Prevention Program designed for delivery by community health workers to socioeconomically disadvantaged populations in low- and middle-income countries (LMICs). Results from the Lifestyle Africa trial conducted in an under-resourced community in South Africa indicated that the programme had a significant effect on reducing haemoglobin A1c (HbA1c).

Objective To estimate the cost of implementation and the cost-effectiveness (in cost per point reduction in HbA1c) of the Lifestyle Africa programme to inform decision-makers of the resources required and the value of this intervention.

Methods Interviews were held with project administrators to identify the activities and resources required to implement the intervention. A direct-measure micro-costing approach was used to determine the number of units and unit cost for each resource. The incremental cost per one point improvement in HbA1c was calculated.

Results The intervention equated to 71 United States dollars (USD) in implementation costs per participant and a 0.26 improvement in HbA1c per participant.

Conclusions Lifestyle Africa reduced HbA1c for relatively little cost and holds promise for addressing chronic disease in LMIC. Decision-makers should consider the comparative clinical effectiveness and cost-effectiveness of this intervention when making resource allocation decisions.		en_US
dc.publisherTaylor and Francis Groupen_US
dc.rights© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectEconomic analysisen_US
dc.subjectHbA1cen_US
dc.subjectLifestyle interventionsen_US
dc.subjectLow- and middle-income countriesen_US
dc.subjectProbabilistic sensitivity analysisen_US
dc.titleCost-effectiveness of Lifestyle Africa: an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africaen_US
dc.typeArticleen_US
kusw.kuauthorFleming, Kandace K.
kusw.kudepartmentLife Span Instituteen_US
dc.identifier.doi10.1080/16549716.2023.2212952en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-7270-8732en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.identifier.pmidPMC10208125en_US
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail
Name:
Whittington_2023.pdf
Size:
1.036Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.
Except where otherwise noted, this item's license is described as: © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.